Medical analysis services for the prediction of response to cancer treatment and its associated clinical outcomes and identification of new drug targets for cancer treatment; medical analysis services for the prediction of response to cancer treatment based on computational analysis of host proteins; medical analysis services for discovering new targets to overcome cancer treatment resistance based on computational analysis of host proteins; medical analysis services to support decision-making regarding the treatment of cancer patients; medical analysis services for the prediction of patients response to cancer treatment and the identification of associated biological mechanisms

'analysi':2,27,40,45,59,64,78 'associ':14,93 'base':37,56 'biolog':94 'cancer':10,24,35,53,75,87 'clinic':15 'comput':39,58 'decis':69 'decision-mak':68 'discov':48 'drug':21 'host':42,61 'identif':18,91 'make':70 'mechan':95 'medic':1,26,44,63,77 'new':20,49 'outcom':16 'overcom':52 'patient':76,84 'predict':6,31,82 'protein':43,62 'regard':71 'resist':55 'respons':8,33,85 'servic':3,28,46,65,79 'support':67 'target':22,50 'treatment':11,25,36,54,73,88

PROPHETNSCLC

Owners

Goods & Services